EyeGene Inc. (KOSDAQ:185490)
South Korea
· Delayed Price · Currency is KRW 1,390.00
+82.00 (6.27%)
At close: Mar 9, 2026
EyeGene Revenue
EyeGene had revenue of 1.10B KRW in the quarter ending September 30, 2025, with 14.36% growth. This brings the company's revenue in the last twelve months to 4.10B, up 25.97% year-over-year. In the year 2024, EyeGene had annual revenue of 3.36B with 7.37% growth.
Revenue (ttm)
4.10B
Revenue Growth
+25.97%
P/S Ratio
14.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
60.09B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aptamer Sciences | 1.08B |
| SunBio,Inc. | 2.17B |
| HLB Pep | 4.89B |
| PanGen Biotech | 15.27B |
| NGeneBio | 9.98B |
| Ark Solutions | 21.50B |
| CHA Vaccine Research Institute | 158.62M |
| J2KBIO | 31.12B |